echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Latest Medical News > Tasly Xiaoyao tablets were approved by the Dutch Drug Review Board

    Tasly Xiaoyao tablets were approved by the Dutch Drug Review Board

    • Last Update: 2021-10-23
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    On September 8, Tasly issued an announcement stating that the company received a notice issued by the Dutch Drug Evaluation Committee regarding the approval of the company’s product Xiaoyao Tablets through drug registration (Traditional UseRegistration), which is used to relieve symptoms such as mental stress and fatigue.


    The company submitted the product registration information of Xiaoyao Tablets in December 2019, passed the preliminary review of the Dutch Drug Evaluation Committee in March 2020, passed the EU GMP certification in December 2020, and obtained product registration approval recently


    The indications of Xiaoyao Tablets recorded in the Chinese Pharmacopoeia are soothing the liver and invigorating the spleen, nourishing blood and regulating menstruation.


    Xiaoyao Tablet is the first compound Chinese medicine variety that has passed the Dutch drug review, and its production line has passed EU GMP certification


    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.